Human Recombinant Heregulin Beta1 (from E. coli)
About this item
Neuregulin/Heregulin is a family of structurally related polypeptide growth factors derived from alternatively spliced genes (NRG1, NRG2, NRG3 and NRG4). To date, there are over 14 soluble and transmembrane proteins derived from the NRG1 gene. Proteolytic processing of the extracellular domain of the transmembrane NRG1 isoforms releases soluble growth factors. HRG1-β1 contains an Ig domain and an EGF-like domain; the latter is necessary for direct binding to receptor tyrosine kinases erb3 and erb4. This binding induces erb3 and erb4 heterodimerization with erb2, stimulating intrinsic kinase activity that leads to tyrosine phosphorylation. Although HRG1-β1's biological effects are still unclear, it has been found to promote motility and invasiveness of breast cancer cells, which may also involve up-regulation of expression and function of the autocrine motility-promoting factor (AMF). Recombinant Human Heregulinβ-1 (HRG1-B1) is a 7.5 kDa polypeptide consisting of only the EGF domain of heregulinβ-1 (65 amino acid residues). Manufactured using all Animal-Free reagents.
- Carrier free
- Animal-free
SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCPNEF TGDRCQNYVM ASFYKHLGIE FMEAE
Verified by N-terminal and Mass Spectrometry analyses (when applicable).
Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.
6 Options Available Below
- Item requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.
- Return Policy
Product Details & Documents
Neuregulin/Heregulin is a family of structurally related polypeptide growth factors derived from alternatively spliced genes (NRG1, NRG2, NRG3 and NRG4). To date, there are over 14 soluble and transmembrane proteins derived from the NRG1 gene. Proteolytic processing of the extracellular domain of the transmembrane NRG1 isoforms releases soluble growth factors. HRG1-β1 contains an Ig domain and an EGF-like domain; the latter is necessary for direct binding to receptor tyrosine kinases erb3 and erb4. This binding induces erb3 and erb4 heterodimerization with erb2, stimulating intrinsic kinase activity that leads to tyrosine phosphorylation. Although HRG1-β1's biological effects are still unclear, it has been found to promote motility and invasiveness of breast cancer cells, which may also involve up-regulation of expression and function of the autocrine motility-promoting factor (AMF). Recombinant Human Heregulinβ-1 (HRG1-B1) is a 7.5 kDa polypeptide consisting of only the EGF domain of heregulinβ-1 (65 amino acid residues). Manufactured using all Animal-Free reagents.
- Carrier free
- Animal-free
SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCPNEF TGDRCQNYVM ASFYKHLGIE FMEAE
Verified by N-terminal and Mass Spectrometry analyses (when applicable).
Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.
Specifications for Product Family
Specifications
Specifications
- Catalog No:
- 10777-946
- 10777-948
- 10777-950
- 10777-952
- 10777-954
- 10777-956
- Protein/peptide name:
- Heregulin Beta1
- Heregulin Beta1
- Heregulin Beta1
- Heregulin Beta1
- Heregulin Beta1
- Heregulin Beta1
- Protein/peptide type:
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Recombinant
- Species:
- Human
- Human
- Human
- Human
- Human
- Human
- Source:
- E. coli
- E. coli
- E. coli
- E. coli
- E. coli
- E. coli
- Animal-free:
- Y
- Y
- Y
- Y
- Y
- Y
- Endotoxin content:
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- <0.1 ng/μg of protein (<1 EU/μg).
- Biological activity:
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.
- The ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.
- Purity:
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Greater than 98% by SDS-PAGE gel and HPLC analyses.
- Formulation:
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Lyophilized
- Storage conditions:
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- −20 °C
- Shipping temperature:
- RT
- RT
- RT
- RT
- RT
- RT
Specifications
Product Family Options
Product Information
- SizeOriginAvailabilityPrice
- Supplier Number: AF-100-03-10UGItem requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.Specifications:
More
Specifications
Cat. No.10777-946Protein/peptide nameHeregulin Beta1Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - Supplier Number: AF-100-03-50UGItem requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.Specifications:
More
Specifications
Cat. No.10777-948Protein/peptide nameHeregulin Beta1Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - Supplier Number: AF-100-03-100UGItem requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.Specifications:
More
Specifications
Cat. No.10777-950Protein/peptide nameHeregulin Beta1Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - Supplier Number: AF-100-03-250UGItem requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.Specifications:
More
Specifications
Cat. No.10777-952Protein/peptide nameHeregulin Beta1Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - Supplier Number: AF-100-03-500UGItem requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.Specifications:
More
Specifications
Cat. No.10777-954Protein/peptide nameHeregulin Beta1Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT - Supplier Number: AF-100-03-1MGItem requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.Specifications:
More
Specifications
Cat. No.10777-956Protein/peptide nameHeregulin Beta1Protein/peptide typeRecombinantSpeciesHumanSourceE. coliAnimal-freeYEndotoxin content<0.1 ng/μg of protein (<1 EU/μg).Biological activityThe ED50 was determined by the dose-dependent stimulation of the proliferation of human MCF-7 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 106 units/mg.PurityGreater than 98% by SDS-PAGE gel and HPLC analyses.FormulationLyophilizedStorage conditions−20 °CShipping temperatureRT



